Adriamycin
Product Images NDC 0143-9547

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Adriamycin (NDC 0143-9547). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Adriamycin Doxorubicin Hydrochloride Injection Usp 1)

Chemical structure diagram of the active ingredient in Adriamycin, showing molecular components and bonds, including a hydrochloride (HCl) component.*

FDA Label Image

Figure 1 And 2 (Adriamycin Doxorubicin Hydrochloride Injection Usp 2)

Two forest plot charts presenting meta-analyses. Figure 1 shows disease-free survival hazard ratios from six Doxo-based studies compared to CMF, listing trials including NSABP B-15 and SE Sweden BCG A. Figure 2 shows overall survival hazard ratios for the same trials. Both charts display hazard ratios with 95% confidence intervals and pooled estimates.*

FDA Label Image

Adriamycin 5 mL Vial Label (Adriamycin Doxorubicin Hydrochloride Injection Usp 3)

Label for Adriamycin Injection, USP (Doxorubicin HCl) by Hikma Pharmaceuticals USA Inc. The sterile isotonic solution is 10 mg per 5 mL (2 mg/mL) in a 5 mL single dose vial, intended for intravenous use only. The label includes dosage instructions, storage requirements, warnings, and distributor information.*

FDA Label Image

Adriamycin 10 mL Vial Label (Adriamycin Doxorubicin Hydrochloride Injection Usp 4)

Label for Adriamycin (doxorubicin HCl) Injection, USP by Hikma Pharmaceuticals USA Inc. The sterile isotonic solution is 20 mg/10 mL (2 mg/mL) in a 10 mL single dose vial for intravenous use. The label includes dosage, storage instructions, and warnings about severe cellulitis, vesication, and tissue necrosis if extravasated.*

FDA Label Image

Adriamycin 25 mL Vial Label (Adriamycin Doxorubicin Hydrochloride Injection Usp 5)

Adriamycin (Doxorubicin HCl) Injection, USP 50 mg/25 mL (2 mg/mL) sterile isotonic solution in a 25 mL single dose vial. Label indicates use for intravenous administration only. Manufactured by Thymoorgan Pharmazie GmbH, Germany, and distributed by West-Ward, Eatontown, NJ USA. Storage and handling instructions include refrigeration and protection from light.*

FDA Label Image

Adriamycin Doxorubicin HCl Injection, Usp 100 mL Vial Label (Adriamycin Doxorubicin Hydrochloride Injection Usp 6)

Adriamycin (Doxorubicin HCl) Injection, USP 200 mg/100 mL (2 mg/mL) sterile isotonic solution for intravenous use only. The label indicates a multiple dose vial containing 100 mL. Manufactured by THYMO-GERMAN PHARMAZIE GmbH, Germany, and distributed by WEST-WARD Pharmaceutical Corp, Eatontown, NJ. Includes dosage and storage instructions.*

FDA Label Image

Representative Carton Serialization Image (Adriamycin Doxorubicin Hydrochloride Injection Usp 7)

A white rectangular pharmaceutical label featuring black text and a QR code on the left. The label lists product tracking info including GTIN, serial number (SN), expiration date (EXP), and lot number (LOT). The label is associated with Adriamycin by Hikma Pharmaceuticals USA Inc.*

FDA Label Image

Representative Carton Serialization Image (Adriamycin Doxorubicin Hydrochloride Injection Usp 8)

Label for Adriamycin by Hikma Pharmaceuticals USA Inc. showing a Data Matrix barcode, lot number ABCDE12345, placeholder expiration date MMMYYYY, GTIN 00301234567896, and serial number 12345678901234. The label is primarily black text on a white background with barcode and product identification details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.